Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: An early step in protection against apoptosis

Cell Death and Differentiation

Volumn 9, Issue 11, 2002, Pages 1248-1255

  Barsacchi, R ^a   Perrotta, C ^a   Sestili, P ^b   Cantoni, O ^b   Moncada, S ^c   Clementi, E ^a,d  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Apoptosis; Cyclic GMP; Nitric oxide; Sphingomyelinases; Tumour necrosis factor

Indexed keywords

CASPASE 8; CERAMIDE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; DNA FRAGMENT; NITRIC OXIDE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR; CYCLOHEXIMIDE; PROTEIN SYNTHESIS INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STIMULATION; CELL STRAIN U937; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CYCLIC GMP; CYCLOHEXIMIDE; HUMANS; NITRIC OXIDE; PROTEIN SYNTHESIS INHIBITORS; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036850413     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401095     Document Type: Article

References (35)

1. Zimmermann KC, Bonzen C and Reed DR (2001) The machinery of programmed cell death. Pharmacol. Ther. 92: 57-70
2. Borner C, Monney L, Olivier R, Rosse T, Hacki J and Conus S (1999) Life and death in a medieval atmosphere. Cell Death Differ. 6: 201-206
3. Liu L and Stamler JS (1999) NO: an inhibitor of cell death. Cell Death Differ. 6: 937-942
4. Takuma K, Phuagphong P, Lee E, Mori K, Baba A and Matsuda T (2001) Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276: 48093-48099
5. Zamora R, Alarcon L, Vodovotz Y, Betten B, Kim PK, Gibson KF and Billiar TR (2001) Nitric oxide suppresses the expression of Bcl-2 binding protein BNIP3 in hepatocytes. J. Biol. Chem. 276: 46887-46895
6. De Nadai C, Sestili P, Cantoni O, Liévremont JP, Sciorati C, Barsacchi R, Moncada S, Meldolesi J and Clementi E (2000) Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide. Proc. Natl. Acad. Sci. USA. 97: 5480-5485
7. Kolesnick, RN and Krönke M (1998) Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60: 643-665
8. Perry DK and Hannun YA (1998) The role of ceramide in cell signaling. Biochim. Biophys. Acta 1436: 233-243
9. Levade T and Jaffrézou J-P (1999) Signalling sphingomyelinases: which, where, how and why? Biophys. Acta 1438: 1-17
10. Sciorati C, Rovere P, Ferrarini M, Heltai S, Manfredi AA and Clementi E (1997) Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. Biol. Chem. 272: 23211-23215
11. Sciorati C, Rovere P, Ferrarini M, Paolucci C, Heltai S, Vaiani R, Clementi E and Manfredi AA (1999) Generation of nitric oxide by the inducible nitric oxide synthase protects γδ T cells from Mycobacterium tuberculosis-induced apoptosis. J. Immunol. 163: 1570-1576
12. Schütze S, Machleidt T, Adam D, Schwandner R, Wiegmann K, Kruse ML, Heinrich M, Wickel M and Krönke M (1999) Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J. Biol. Chem. 274: 10203-10212
13. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Pleiss U, Schroder H, Schroeder W, Stahl E, Steinke W, Straub A and Schramm M (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410: 212-215
14. Moncada S and Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9: 1319-1330
15. Gadbois DM, Crissman HA, Tobey RA and Bradbury EM (1992) Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. USA. 89: 8626-8630
16. Lozano J, Menendez S, Morales A, Ehleiter D, Liao WC, Wagman R, Haimovitz-Friedman A, Fuks Z and Kolesnick R (2001) Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276: 442-448
17. Ségui B, Cuvillier O, Adam-Klages S, Garcia V, Malagarie-Cazenave S, Lévéque S, Caspar-Bauguil S, Coudert J, Salvayre R, Krönke M and Levade T (2001) Involvement of FAN in TNF-induced apoptosis. J. Clin. Invest. 108: 143-151
18. Jensen JM, Schütze S, Forl M, Krönke M and Proksch E (1999) Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J. Clin. Invest. 104: 1761-1770
19. Garcìa-Ruiz C, Mari M, Morales A, Colell A, Ardite E and Fernandez-Checa JC (2000) Human placenta sphingomyelinase, an exogenous acidic pH-optimum sphingomyelinase, induces oxidative stress, glutathione depletion, and apoptosis in rat hepatocytes. Hepatol. 32: 56-65
20. Tanaka M, Nara, F, Suzuki-Konagai K, Hosoya T and Ogita T (1997) Structural elucidation of scyphostatin, an inhibitor of membrane-bound neutral sphingomyelinase. J. Am. Chem. Soc. 116: 7871-7872
21. Andrieu-Abadie N, Jaffrézou JP, Hatem S, Laurent G, Levade T and Mercaider JJ (1999) L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J. 13: 1501-1510
22. Brenner B, Ferlinz K, Grassmé H, Weller M, Koppenhoefer U, Dichigans J, Sandhoff K, Lang F and Gulbins E (1998) Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ. 5: 29-37
23. Schwandner R, Wiegmann K, Bernardo K, Kreder D and Krönke M (1998) TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J. Biol. Chem. 273: 5916-5922
24. Dbaibo GS, Perry DK, Gamard CJ, Platt R, Poirier GG, Obeid LM and Hannun YA (1997) Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α CrmA and Bcl-2 target distinct components in the apoptotic pathway. J. Exp. Med. 85: 481-490
25. Jayadev S, Hayter HL, Andrieu N, Gamard CJ, Liu B, Balu R, Hayakawa M, Ito F and Hannun Y (1997) Phospholipase A2 is necessary for tumor necrosis factor α-induced ceramide generation in L929 cells. J. Biol. Chem. 272: 17196-17203
26. Mansat V, Laurent G, Levade T, Bettaieb A and Jeffrézou JP (1997) The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57: 5300-5304
27. Ségui B, Bezombes C, Uro-Coste E, Medin JA, Andrieu-Abadie N, Auge N, Brouchet A, Laurent G, Salvayre R, Jaffrézou JP and Levade T (2000) Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14: 36-47
28. Grassmé H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R and Gulbins E (2001) CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276: 20589-20596
29. Birbes H, El Bawab S, Hannun YA and Obeid LM (2001) Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15: 2669-2679
30. Garcìa-Ruiz C, Colell A, Mari M, Morales A and Fernandez-Checa JC (1997) Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272: 11369-11377
31. Ghafourifar P, Klein SD, Schucht O, Schenk U, Pruschy M, Rocha S and Richter C. (1999) Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J. Biol. Chem. 274: 6080-6088
32. Beltràn B, Mathur A, Duchen MR, Erusalimsky JD and Moncada S (2000) The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc. Natl. Acad. Sci. USA. 97: 14602-14607
33. Brown GC (1999) Nitric oxide and mitochondrial respiration. Biochim. Biophys. Acta 1411: 351-369
34. Bulotta S, Barsacchi R, Rotiroti D, Borgese N and Clementi E (2001) Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-α. A novel feedback mechanism regulating cell death. J. Biol. Chem. 276: 6529-6536
35. Li XA, Titlow WB, Jackson BA, Giltiay N, Nikolova-Karakashian M, Uittenbogaard A and Smart EJ (2002) High-density lipoprotein binding to scavenger receptor class B, type I activates endothelial nitric oxide synthase in a ceramide-dependent manner. J. Biol. Chem. 277: 11058-11063